{
    "eid": "2-s2.0-85147172810",
    "title": "Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma",
    "cover-date": "2023-01-17",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "cholangiocarcinoma",
        "ferroptosis",
        "gene signature",
        "prognosis",
        "risk score"
    ],
    "authors": [
        "Apiwit Sae-fung",
        "Apiwat Mutirangura",
        "Siriporn Jitkaew"
    ],
    "citedby-count": 3,
    "ref-count": 99,
    "ref-list": [
        "Cholangiocarcinoma 2020: The next horizon in mechanisms and management",
        "Operative considerations in resection of hilar cholangiocarcinoma",
        "Liver resection and transplantation for intrahepatic cholangiocarcinoma",
        "Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: A comparative multicentre study in Japan",
        "Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer",
        "Precision medicine in biliary tract cancer",
        "Ferroptosis: Mechanisms, biology and role in disease",
        "Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications",
        "Ferroptosis: An iron-dependent form of nonapoptotic cell death",
        "Pharmacological inhibition of cystine\u2013glutamate exchange induces endoplasmic reticulum stress and ferroptosis",
        "Regulation of ferroptotic cancer cell death by Gpx4",
        "The role of ferroptosis in cancer development and treatment response",
        "Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma",
        "Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma",
        "Targeting ferroptosis to iron out cancer",
        "Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease",
        "Ferrdb: A manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations",
        "The string database in 2011: Functional interaction networks of proteins, globally integrated and scored",
        "Determining cell type abundance and expression from bulk tissues with digital cytometry",
        "Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression",
        "Epic: A tool to estimate the proportions of different cell types from bulk gene expression data",
        "Prrophetic: An r package for prediction of clinical chemotherapeutic response from tumor gene expression levels",
        "Establishment and characterization of a cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer",
        "Establishment and characterization of a cholangiocarcinoma cell line (Rmcca-1) from a Thai patient",
        "Proteomics. tissue-based map of the human proteome",
        "Dysregulation of iron metabolism in cholangiocarcinoma stem-like cells",
        "Regulation of iron homeostasis by the P53-iscu pathway",
        "Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma",
        "Mir-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase Got1 in melanoma",
        "Fancd2 protects against bone marrow injury from ferroptosis",
        "Expression and prognostic characteristics of ferroptosis-related genes in colon cancer",
        "Comprehensive analysis of the autophagy-dependent ferroptosis-related gene Fancd2 in lung adenocarcinoma",
        "A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma",
        "Ferroptosis-related gene signature predicts glioma cell death and glioma patient progression",
        "Prognostic significance of prostaglandin-endoperoxide synthase-2 expressions in human breast carcinoma: A multiomic approach",
        "Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention",
        "Cyclooxygenase-2 in cancer: A review",
        "Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy",
        "Cyclooxygenase-2-Derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through Ep1 receptor-mediated activation of the epidermal growth factor receptor and akt",
        "Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma",
        "Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma",
        "Targeting Glut1 and the warburg effect in renal cell carcinoma by chemical synthetic lethality",
        "High Slc2a1 expression associated with suppressing Cd8 T cells and b cells promoted cancer survival in gastric cancer",
        "Trim38 triggers the uniquitination and degradation of glucose transporter type 1 (Glut1) to restrict tumor progression in bladder cancer",
        "Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis",
        "A novel ferroptosis-related 4-gene prognostic signature for cholangiocarcinoma and photodynamic therapy",
        "Dysregulation of the mir-148a-Glut1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma",
        "Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death",
        "Ferroptosis regulators, especially sqle, play an important role in prognosis, progression and immune environment of breast cancer",
        "Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma",
        "A novel ferroptosis-related prognostic signature reveals macrophage infiltration and emt status in bladder cancer",
        "Golgi stress mediates redox imbalance and ferroptosis in human cells",
        "Organelle-specific regulation of ferroptosis",
        "Metabolic regulation of ferroptosis in the tumor microenvironment",
        "Increased activation of Pi3k/Akt signaling pathway is associated with cholangiocarcinoma metastasis and Pi3k/Mtor inhibition presents a possible therapeutic strategy",
        "Phosphoinositide signalling in cancer: Beyond Pi3k and pten",
        "The mtor signalling pathway in human cancer",
        "Targeting the Pi3k/Akt/Mtor pathway in biliary tract cancers: A review of current evidences and future perspectives",
        "Apatinib inhibits vegf signaling and promotes apoptosis in intrahepatic cholangiocarcinoma",
        "Vegf in signaling and disease: Beyond discovery and development",
        "Role of erbb family receptor tyrosine kinases in intrahepatic cholangiocarcinoma",
        "Erbb receptors and signaling pathways in cancer",
        "Wnt signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited",
        "Wnt signaling in cancer",
        "Mitogen-activated protein kinases (Mapks) and cholangiocarcinoma: The missing link",
        "Map kinase signalling pathways in cancer",
        "Immune system: A double-edged sword in cancer",
        "Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules",
        "Metabolic regulation of tregs in cancer: Opportunities for immunotherapy",
        "Regulatory T cells in cancer immunotherapy",
        "Regulatory T cells in tumor immunity",
        "Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma",
        "Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma",
        "From the regulatory functions of b cells to the identification of cytokine-producing plasma cell subsets",
        "Immunosuppressive plasma cells impede T-Cell-Dependent immunogenic chemotherapy",
        "The dark side of fibroblasts: Cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment",
        "Paclitaxel restores sensitivity to chemotherapy in preclinical models of multidrug-resistant intrahepatic cholangiocarcinoma",
        "Kinase drug discovery 20 years after imatinib: Progress and future directions",
        "Metastatic non-small cell lung cancer: Esmo clinical practice guidelines for diagnosis, treatment and follow-up",
        "Effect of combining egfr tyrosine kinase inhibitors and cytotoxic agents on cholangiocarcinoma cells",
        "Targeting pdgfr-beta in cholangiocarcinoma",
        "Platelet-derived growth factor-d enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma",
        "Analysis of differentially expressed mrnas and the prognosis of cholangiocarcinoma based on tcga database",
        "Survival analysis of genome-wide profiles coupled with connectivity map database mining to identify potential therapeutic targets for cholangiocarcinoma",
        "Polo-like kinase 1 inhibition as a new therapeutic modality in therapy of cholangiocarcinoma",
        "New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing",
        "Safety and antitumor activity of the multitargeted pan-trk, Ros1, and alk inhibitor entrectinib: Combined results from two phase I trials (Alka-372-001 and startrk-1)",
        "Prognostic significance of overexpression of c-met oncoprotein in cholangiocarcinoma",
        "C-met in intrahepatic cholangiocarcinoma: High-frequency amplification predicts protein expression and a unique molecular subtype",
        "Targeting c-met by Ly2801653 for treatment of cholangiocarcinoma",
        "Targeting c-met by tivantinib through synergistic activation of Jnk/C-jun pathway in cholangiocarcinoma",
        "Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis",
        "Gsk3beta inhibition promotes doxorubicin-induced apoptosis in human cholangiocarcinoma cells Via Fak/Akt inhibition",
        "Cholangiocarcinoma - evolving concepts and therapeutic strategies",
        "Immunotherapy of biliary tract cancer",
        "Ferroptosis-related gene signature predicts the prognosis in oral squamous cell carcinoma patients",
        "Identification and validation of a prognostic signature for prostate cancer based on ferroptosis-related genes",
        "Identification of a ferroptosis-related gene signature predictive model in colon cancer",
        "Oncogenic kras requires complete loss of Bap1 function for development of murine intrahepatic cholangiocarcinoma"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ratchadaphiseksomphot Endowment Fund",
        "Thailand Science Research and Innovation Fund Chulalongkorn University",
        "Chulalongkorn University",
        "National Research Council of Thailand"
    ]
}